HEATR1 negatively regulates Akt to increase the cancer cells’ sensitivity to chemotherapy, making it a possible predictive and prognostic biomarker for treatment responsiveness and the prognosis of patients with pancreatic cancer, according to Liu et al. (Liu et al., 2016). Here, HEATR1 is linked to familial pancreatic carcinoma.